HCV-796: Preliminary Phase Ib data

Preliminary data from a double-blind, placebo-controlled, dose-escalation, U.S. Phase Ib trial in 96 evaluable treatment-naïve chronic HCV patients showed that 1,000 mg HCV-796 led to a peak mean HCV ...